The EPICUP test is a new tool that helps identify up to 87% of cases of cancer of unknown origin (CUP).
Regeneron and Sanofi announced detailed positive results from ODYSSEY ESCAPE, a Phase 3 trial which evaluated Praluent (alirocumab) Injection.
The U.S. Food and Drug Administration issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche, skirting normal approval channels as the regulator moves to fight the disease’s spread.
Nearly a third of U.S. counties likely will be served by only one insurer that participates in an Affordable Care Act (ACA) marketplace in 2017, according to an analysis published by the Kaiser Family Foundation.
Adults with longer-lived parents have a lower-than-average risk for problems with the body’s circulatory system in middle age, British researchers have found.
Mylan is drawing fire for passing off massive price hikes for its EpiPen allergy treatment. But it’s far from being the drug company with the most pricing power.
UK-based AstraZeneca has placed its U.S. headquarters located in Fairfax, Delaware, up for sale. However, the company indicates that it is evaluating several options for the site, including redevelopment, and should not be viewed as abandoning Delaware or even the Fairfax area.
The U.S. Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for “knowingly” releasing 27 lots of the hypertension drug clonidine during 2015, despite proof that the raw materials used may have been contaminated.
Takeda announced the launch of an Access to Medicines (AtM) strategy aimed at increasing access to its innovative and potentially life-saving medicines.
Blood-testing company Theranos Inc. said it plans to appeal the sanctions imposed by a U.S. regulator on one of its labs alleging its practices jeopardized patient health and safety.